The archive doesn't directly address NHS prescribing of digital therapeutics. Better Therapeutics' founders describe a vision where digital therapeutics receive prescriptions first, before drugs, for metabolic disease [#228], and Sleepio's team noted that NHS aims cannot be met without digital therapeutics as a significant component [Ep 20]. But neither confirms current NHS prescription status or pathway.
The retrieved material shows that digital therapeutics are already distributed through multiple channels: employer benefits, direct-to-consumer sales, and telemedicine platforms [#228]. What's absent is evidence of formal NHS commissioning or prescribing routes.
To answer this properly, you'd want to ask: which digital therapeutics currently hold NHS approval or NICE recommendation, and what does the commissioning pathway look like? That's a sharper question than the archive directly answers.
Search 450+ episodes and 42,000 chunks of healthtech conversation.